Furthermore, El-Tanani MK et al demonstrated that BRCA1 mutation lead to OPN overexpression resulting in proliferation of breast cancer cells in a rat mammary model system [43], thus OPN could also be an important biomarker in the development of OC in BRCA1 mutation carriers. The gene discussed is BRCA1; the disease is breast carcinoma.